NAT10 and hepatocellular carcinoma: In conclusion, this study demonstrated that NAT10, an ac4C-modifying protein, plays an important role in HCC metastasis, lenvatinib resistance, and ERS of HCC cells by regulating the mRNA ac4C-modifying pathway.